Product
67Cu-SARTATE
Aliases
Cu-67 SARTATE, copper 67 SARTATE
1 clinical trial
1 indication
Indication
NeuroblastomaClinical trial
67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk Neuroblastoma: A Multi-center, Dose-escalation, Open-label, Non-randomized, Phase 1-2a Theranostic Clinical TrialStatus: Recruiting, Estimated PCD: 2028-12-01